Stay updated on Pembrolizumab CNS Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision label on the ClinicalTrials.gov 403 error page changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T23:28:46.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the page itself continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T05:49:48.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, making the study record inaccessible. This indicates an access issue rather than an update to the study content.
    Difference
    22%
    Check dated 2026-09-21T23:54:16.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.5 to v3.6.6, indicating an internal update to the page rendering or metadata. The change does not modify the study content or data presented on the page.
    Difference
    0.0%
    Check dated 2026-08-31T18:54:23.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a deployed update to the page. No visible changes to the study details or layout are reflected in the provided data.
    Difference
    0.0%
    Check dated 2026-08-10T13:24:27.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Investigator and affiliation details were updated: Nancy Wang, M.D., Massachusetts General Hospital, with credentials added, and Priscilla Brastianos, MD, removed from the record. This reflects a change in the study's listed leadership and contact information for NCT02886585.
    Difference
    0.5%
    Check dated 2026-07-27T05:54:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.